---
title: BPI Theater @ BIO 2020 Virtual
description: BPI Theater at BIO 2020 - Speakers analyzed how companies are responding to manufacturing challenges raised by COVID-19 and emerging modalities.
image: https://bpi.bioprocessintl.com/hubfs/BPI-Theater-header.jpg
---
- [Subscribe](https://www.sub-forms.com/dragon/init.do?site=INF1_BQland)
- | [Contribute](http://www.bioprocessintl.com/about/author-guidelines/)
- | [About](http://www.bioprocessintl.com/about/)
- | [Register](http://www.bioprocessintl.com/register/)
- | [Login](http://www.bioprocessintl.com/login/)
| | |
| --- | --- |
[ ](http://www.bioprocessintl.com/)
- [Upstream Processing](http://www.bioprocessintl.com/topic/upstream-processing/)
- Read More concerning Upstream Processing
- [Assays](http://www.bioprocessintl.com/category/upstream-processing/assays/)
- [Biochemicals/Raw Materials](http://www.bioprocessintl.com/category/upstream-processing/biochemicals-raw-materials/)
- [Bioreactors](http://www.bioprocessintl.com/category/upstream-processing/bioreactors/)
- [Cell Culture Media](http://www.bioprocessintl.com/category/upstream-processing/fermentation/)
- [Expression Platforms](http://www.bioprocessintl.com/category/upstream-processing/fermentation/)
- [Fermentation](http://www.bioprocessintl.com/category/upstream-processing/fermentation/)
- [Upstream Contract Services](http://www.bioprocessintl.com/category/upstream-processing/upstream-contract-services/)
- [Upstream Single-Use Technologies](http://www.bioprocessintl.com/category/upstream-processing/upstream-single-use-technologies/)
- [Downstream Processing](http://www.bioprocessintl.com/topic/downstream-processing/)
- Read More concerning Downstream Processing
- [Filtration](http://www.bioprocessintl.com/category/downstream-processing/filtration/)
- [Separation/Purification](http://www.bioprocessintl.com/category/downstream-processing/viral-clearance/)
- [Viral Clearance](http://www.bioprocessintl.com/category/downstream-processing/viral-clearance/)
- [Chromatography](http://www.bioprocessintl.com/category/downstream-processing/downstream-contract-services/)
- [Downstream Contract Services](http://www.bioprocessintl.com/category/downstream-processing/downstream-contract-services/)
- [Downstream Single-Use Technologies](http://www.bioprocessintl.com/category/downstream-processing/downstream-single-use-technologies/)
- [Manufacturing](http://www.bioprocessintl.com/topic/manufacturing/)
- Read More concerning Manufacturing
- [Personalized Medicine](http://www.bioprocessintl.com/category/manufacturing/personalized-medicine/)
- [Single Use](http://www.bioprocessintl.com/category/manufacturing/vaccines/)
- [Supply Chain](http://www.bioprocessintl.com/category/manufacturing/vaccines/)
- [Vaccines](http://www.bioprocessintl.com/category/manufacturing/vaccines/)
- [Antibody and Nonantibody](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/)
- [Biosimilars](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/)
- [Cell Therapies](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/)
- [Facility Design/Engineering](http://www.bioprocessintl.com/category/manufacturing/facility-design-engineering/)
- [Fill/Finish](http://www.bioprocessintl.com/category/manufacturing/fill-finish/)
- [Formulation](http://www.bioprocessintl.com/category/manufacturing/formulation/)
- [Information Technology](http://www.bioprocessintl.com/category/manufacturing/information-technology/)
- [Manufacturing Contract Services](http://www.bioprocessintl.com/category/manufacturing/manufacturing-contract-services/)
- [Analytical](http://www.bioprocessintl.com/topic/analytical/)
- Read More concerning Analytical
- [Culture Development](http://www.bioprocessintl.com/category/analytical/culture-development/)
- [Downstream Development](http://www.bioprocessintl.com/category/analytical/downstream-development/)
- [Downstream Validation](http://www.bioprocessintl.com/category/analytical/downstream-validation/)
- [Laboratory Equipment](http://www.bioprocessintl.com/category/analytical/laboratory-equipment/)
- [PAT](http://www.bioprocessintl.com/category/analytical/pat/)
- [Pre-Formulation](http://www.bioprocessintl.com/category/analytical/pre-formulation/)
- [Product Characterization](http://www.bioprocessintl.com/category/analytical/product-characterization/)
- [QA/QC](http://www.bioprocessintl.com/category/analytical/qa-qc/)
- [Upstream Development](http://www.bioprocessintl.com/category/analytical/upstream-validation/)
- [Upstream Validation](http://www.bioprocessintl.com/category/analytical/upstream-validation/)
- [Leachables/Extractables/Particulates](http://www.bioprocessintl.com/category/analytical/leachables-extractables-particulates/)
- [Business](http://www.bioprocessintl.com/topic/business/)
- Read More concerning Business
- [Careers](http://www.bioprocessintl.com/category/business/careers/)
- [CMC Forums](http://www.bioprocessintl.com/category/business/cmc-forums/)
- [Economics](http://www.bioprocessintl.com/category/business/economics/)
- [Intellectual Property](http://www.bioprocessintl.com/category/business/intellectual-property/)
- [Pre-Clinical and Clinical Trials](http://www.bioprocessintl.com/category/business/pre-clinical-and-clinical-trials/)
- [Regulatory Affairs](http://www.bioprocessintl.com/category/business/regulatory-affairs/)
- [Risk Management](http://www.bioprocessintl.com/category/business/risk-management/)
- [BioRegions](http://www.bioprocessintl.com/category/business/bioregions/)
- [Home](http://www.bioprocessintl.com/)
- [Archive](http://www.bioprocessintl.com/issue-archive/)
- [Current Issue](https://bpi.bioprocessintl.com/2017-yearbook)
- [Featured Reports](http://www.bioprocessintl.com/featured-reports/)
- [eBooks](http://www.bioprocessintl.com/ebooks/)
- [Multimedia](http://www.bioprocessintl.com/category/multimedia/)
- [Events](http://www.bioprocessintl.com/events-calendar/)
- [News](http://www.bioprocessintl.com/category/news/)
- [Upstream Processing](http://www.bioprocessintl.com/topic/upstream-processing/)
- [Downstream Processing](http://www.bioprocessintl.com/topic/downstream-processing/)
- [Manufacturing](http://www.bioprocessintl.com/topic/manufacturing/)
- [Analytical](http://www.bioprocessintl.com/topic/analytical/)
- [Business](http://www.bioprocessintl.com/topic/business/)
| *These interviews, presentations, and panel discussions took place at the BPI Theater at BIO 2020. Centering the presentations around two key themes — emerging therapies and technologies — enabled theater speakers and attendees to engage complex, interconnected topics that are of interest to* BPI *readers. Speakers highlighted how their companies are responding to both challenges and opportunities relating to manufacturing technique and capacity, particularly where it concerns expressing and mass-producing novel proteins. Presenters also reflected on how far the biopharmaceuticals industry has come, the challenges it faces with COVID-19, and where it can go in the age of individualized cell and gene therapies.* *View the full presentations by following the links below.* |
| --- |
| [](https://bioprocessintl.com/sponsored-content/bioseparations-tools-bioprocess-insider-interviews-steve-burton/) **[*BioProcess Insider* Interviews: Steve Burton, Chief Executive Officer, Astrea Bioseparations](https://bioprocessintl.com/sponsored-content/bioseparations-tools-bioprocess-insider-interviews-steve-burton/)** |
| --- |
| [](https://bioprocessintl.com/sponsored-content/cdmo-industry-trends-bioprocess-insider-interviews-timothy-compton/) **[*BioProcess Insider* Interviews: Timothy Compton, Chief Commercial Officer, Avid Bioservices](https://bioprocessintl.com/sponsored-content/cdmo-industry-trends-bioprocess-insider-interviews-timothy-compton/)** |
| --- |
| [](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapy-manufacturers-bioprocess-insider-interviews-felix-hsu/) **[*BioProcess Insider* Interviews: Felix Hsu, Chief Commercial and Business Officer, WuXi Advanced Therapies](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapy-manufacturers-bioprocess-insider-interviews-felix-hsu/)** |
| --- |
| [](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapy-capabilities-bioprocess-insider-interviews-julien-meissonnier/) **[*BioProcess Insider* Interviews: Julien Meissonnier, Vice President and Chief Scientific Officer, Catalent Biologics](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapy-capabilities-bioprocess-insider-interviews-julien-meissonnier/)** |
| --- |
| [](https://bioprocessintl.com/sponsored-content/bioprocess-insider-interviews-kevin-sharp-about-expanding-ancillary-services/) **[*BioProcess Insider* Interviews: Kevin Sharp, Director, Global Business Development Center, Samsung Biologics](https://bioprocessintl.com/sponsored-content/bioprocess-insider-interviews-kevin-sharp-about-expanding-ancillary-services/)** |
| --- |
| [](https://bioprocessintl.com/sponsored-content/manufacture-of-crispr-rnps-for-clinical-use/) [**Manufacture of CRISPR RNPs for Clinical Use**](https://bioprocessintl.com/sponsored-content/manufacture-of-crispr-rnps-for-clinical-use/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapeutic-manufacturing-innovative-flexible-strategies-catalent/) [**Technology Integrators in Cell and Gene Therapy: Powering Innovation**](https://bioprocessintl.com/sponsored-content/cell-and-gene-therapeutic-manufacturing-innovative-flexible-strategies-catalent/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/development-of-a-platform-for-advanced-viral-therapies/) [**Development of an Advanced Gene Therapy Platform**](https://bioprocessintl.com/sponsored-content/development-of-a-platform-for-advanced-viral-therapies/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/regulatory-strategy-meeting-requirements-for-cell-and-gene-therapy-manufacturing/) [**Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing**](https://bioprocessintl.com/sponsored-content/regulatory-strategy-meeting-requirements-for-cell-and-gene-therapy-manufacturing/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/serum-free-suspension-lentiviral-vector-platform-manufacturing-process-for-cell-therapy/) [**Accelerating Clinical Development and Commerialization with a Lentiviral Vector Platform Manufacturing Process for Cell Therapy**](https://bioprocessintl.com/sponsored-content/serum-free-suspension-lentiviral-vector-platform-manufacturing-process-for-cell-therapy/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/stainless-steel-and-single-use-systems-supply-chain-management-observations-from-covid-19/) [**Stainless-Steel and Single-Use Systems: Observations from COVID-19**](https://bioprocessintl.com/sponsored-content/stainless-steel-and-single-use-systems-supply-chain-management-observations-from-covid-19/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/get-to-ind-faster-accelerated-high-performance-cell-line-development-with-glutamine-synthase-knockout/) [**Get to IND Faster: Accelerated, High-Performance Cell-Line Development**](https://bioprocessintl.com/sponsored-content/get-to-ind-faster-accelerated-high-performance-cell-line-development-with-glutamine-synthase-knockout/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/an-innovative-closed-car-t-cell-therapy-platform-process-to-streamline-manufacturing-approaches-with-great-predictability/) [**An Innovative, Closed, CAR T-Cell Therapy Platform Process to Streamline Manufacturing Approaches with Great Predictability**](https://bioprocessintl.com/sponsored-content/an-innovative-closed-car-t-cell-therapy-platform-process-to-streamline-manufacturing-approaches-with-great-predictability/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/from-target-to-hit-the-wuxi-hits-platform-and-dna-encoded-libraries/) [**From Target to Hit: The WuXi HitS Platform**](https://bioprocessintl.com/sponsored-content/from-target-to-hit-the-wuxi-hits-platform-and-dna-encoded-libraries/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/the-road-to-commercial-biologics-manufacturing-a-cdmo-perspective/) [**The Road to Commercialization: A CDMO Perspective**](https://bioprocessintl.com/sponsored-content/the-road-to-commercial-biologics-manufacturing-a-cdmo-perspective/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/plasmid-dna-manufacturing-excellence-the-foundation-for-multiple-new-modalities/) [**Plasmid Manufacturing Excellence: The Foundation for Multiple New Modalities**](https://bioprocessintl.com/sponsored-content/plasmid-dna-manufacturing-excellence-the-foundation-for-multiple-new-modalities/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/gpex-boost-a-novel-approach-for-high-expressing-cho-cell-line-engineering/) [**GPEx Boost: A Novel Approach for High-Expressing CHO Cell-Line Engineering**](https://bioprocessintl.com/sponsored-content/gpex-boost-a-novel-approach-for-high-expressing-cho-cell-line-engineering/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/crispr-library-screens-for-oncology-target-discovery-at-wuxi-apptec/) [**CRISPR Library Screens for Oncology Target Discovery at WuXi AppTec**](https://bioprocessintl.com/sponsored-content/crispr-library-screens-for-oncology-target-discovery-at-wuxi-apptec/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/solutions-for-rapid-development-and-manufacturing-responses-to-covid-19-and-other-public-health-threats/) [**Solutions for Rapid Development and Manufacturing Responses to COVID-19 and Other Public Health Threats**](https://bioprocessintl.com/sponsored-content/solutions-for-rapid-development-and-manufacturing-responses-to-covid-19-and-other-public-health-threats/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/a-holistic-and-integrated-ind-development-approach-committing-to-quality-reliability-and-speed/) [**A Holistic and Integrated CMC Development Approach: Committing to Quality, Reliability, and Speed**](https://bioprocessintl.com/sponsored-content/a-holistic-and-integrated-ind-development-approach-committing-to-quality-reliability-and-speed/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/a-new-outsourcing-business-model-to-accelerate-development-of-life-preserving-therapies/) [**New Business and Funding Models to Accelerate Development of Life-Preserving Therapies**](https://bioprocessintl.com/sponsored-content/a-new-outsourcing-business-model-to-accelerate-development-of-life-preserving-therapies/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/an-end-to-end-integrated-solutions-approach-to-commercial-viral-vector-manufacturing/) [**An End-to-End Integrated-Solutions Approach to Commercial Viral Vector Manufacturing**](https://bioprocessintl.com/sponsored-content/an-end-to-end-integrated-solutions-approach-to-commercial-viral-vector-manufacturing/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/securing-your-manufacturing-capacity-during-the-covid-19-pandemic/) [**Securing Your Manufacturing Capacity During the Pandemic**](https://bioprocessintl.com/sponsored-content/securing-your-manufacturing-capacity-during-the-covid-19-pandemic/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/leveraging-infrastructure-investments-for-single-use-capacity-to-accelerate-biologics-development/) [**Leveraging Infrastructure Investments and Innovation to Accelerate Biologics Development**](https://bioprocessintl.com/sponsored-content/leveraging-infrastructure-investments-for-single-use-capacity-to-accelerate-biologics-development/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/will-in-house-manufacturing-capabilities-give-cell-and-gene-therapy-developers-competitive-advantages/) [**Will In-House Manufacturing Capabilities Give Cell and Gene Therapy Developers Competitive Advantages?**](https://bioprocessintl.com/sponsored-content/will-in-house-manufacturing-capabilities-give-cell-and-gene-therapy-developers-competitive-advantages/) |
| --- |
| [](https://bioprocessintl.com/bpi-theater/bpi-theater-bio-2020/biologics-development-services-the-evolving-role-of-the-outsourcing-manufacturer-why-cdmo-is-the-new-normal/) [**The Evolving Role of the Outsourcing Manufacturer: Why CDMO Is the New Normal**](https://bioprocessintl.com/bpi-theater/bpi-theater-bio-2020/biologics-development-services-the-evolving-role-of-the-outsourcing-manufacturer-why-cdmo-is-the-new-normal/) |
| --- |
| [](https://bioprocessintl.com/sponsored-content/vector-production-the-role-of-new-technologies-in-enabling-cell-and-gene-therapies/) [**The Role of New Technology in Enabling Cell and Gene Therapies**](https://bioprocessintl.com/sponsored-content/vector-production-the-role-of-new-technologies-in-enabling-cell-and-gene-therapies/) |
| --- |
-
-
©2015 BioProcess International All Rights reserved